No abstract available.
Lipoproteins*

The study was carried out on 39 patients who had hypertension of degree I, II, with lipidemia but without complications to investigate lipoproteins HDL-C, LDL-C of them. The results showed that: concentration of HDL-C increased by 12.5%, concentration of LDL-C decreased by 12.9% (p<0.001) after 30 days of treatment with antihypertensive herbal remedy Nguu tat, Hoe nhai, Linh chi. The results indicated that the remedy had good effects and reduced risk factors of atherosclerosis and hyperlipaemia
Hypertension ; Lipoproteins

No abstract available.
Lipoproteins ; Wind

OBJECTIVE: To analyze and characterize the separation effectiveness of self-constructed asymmetrical flow field-flow fractionation system on proteins and lipoproteins, to achieve the optimization of the experimental conditions when separating lipoproteins by orthogonal design test and to investigate the carrier viscosity's influence on separation effectiveness. METHODS: The evaluation of asymmetrical flow field-flow fractionation separation capacity was conducted by using two standard proteins (carbonic anhydrase and thyroglobulin). Under the optimized separation conditions of carbonic anhydrase and thyroglobulin, the channel actual thickness (after assembling, the actual thickness of separation channel was less than initial thickness) was calculated by the analytes' elution time based on the hydrokinetic theory. With orthogonal design test the optimized experimental conditions were studied and statistical analysis was carried on to find out the factors with statistical significance which needed further exploration. RESULTS: According to the hydrodynamics principle and Stoke's function, the channel actual thickness was measured to be 164 μm by separating the two standard proteins, carbonic anhydrase and thyroglobulin, under proper experimental conditions. By the optimization based on orthogonal design test, base-line separation (the resolution had to be higher than 1.50) was achieved. The resolutions of the two experiments were 1.61 and 1.58. According to previous study/ pre-study and supporting theory, in the orthogonal design test, the total 5 factors were integrated for comprehensive investigation: the total flow rate (3.00, 3.50, 4.00, 4.50 mL/min), focus time (3.00, 3.50, 4.00, 4.50 min), transition time (0.5, 1.0, 1.5, 2.0 min), pH of the carrier fluid(6.8, 7.00, 7.20, 7.40) and viscosity of the carrier fluid hydroxypropylmethylcellulose concentration: 0.00%, 0.03%, 0.06%, 1.00%). Among the 5 factors, viscosity was found to have the statistical significance on separation effectiveness which was further investigated. The resolution of high density lipoprotein and low density lipoprotein was increased by the increasing viscosity which also caused more obvious negative spikes. CONCLUSION The separating capacities of self-constructed asymmetrical flow field-flow fractionation system on lipoproteins were verified to be effective and an optimized experimental condition was found to achieve the base-line separation of high density lipoprotein and low density lipoprotein. Viscosity of the carrier fluid was proved to have the statistical significance on lipoprotein separation.
Fractionation, Field Flow ; Lipoproteins ; Lipoproteins, LDL

No abstract available.
Humans ; Lipoproteins* ; Nephrotic Syndrome*

No abstract available.
Lipoproteins* ; Nephrosis, Lipoid*

A study on 31 patients with chronic renal failure treated by periodical hemodialysis during 1995 - 1999 has shown that the rate of blood lipoprotein disorder was 56 -60%, this disorder was not improved by periodical hemodialysis. Most frequent disorder was disorder of ApoB, followed by triglyceride, HDL-C and LDL-C. Indicator of cholesterol/HDL-C and LDL-C increased significantly as increased time. The blood lipid disorder increased significantly in the group of hypertensive patients with periodical hemodialysis. The major cause of death was cardiovascular complications.
Kidney Failure, Chronic ; Lipoproteins

No abstract available.
Cardiopulmonary Bypass* ; Lipoproteins* ; Plasma*

No abstract available.
Apoproteins* ; Diabetic Nephropathies* ; Lipoproteins*

No abstract available.
Female ; Humans ; Lipoproteins*